United States · FDA National Drug Code directory
LIRAGLUTIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-920_30ecdada-240d-4f5b-a900-5705e4b500be
- Product NDC
- 69097-920
- Form
- INJECTION, SOLUTION
- Composition / generic term
- LIRAGLUTIDE
- Labeler
- Cipla USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260122
- Source listing expiry
- 20271231
Source-listed ingredients
- LIRAGLUTIDE — 6 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 SYRINGE, PLASTIC in 1 CARTON (69097-920-67) / 3 mL in 1 SYRINGE, PLASTIC · 69097-920-67
- 3 SYRINGE, PLASTIC in 1 CARTON (69097-920-68) / 3 mL in 1 SYRINGE, PLASTIC · 69097-920-68
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →